P1269: VIP152 IS A NOVEL CDK9 INHIBITOR WITH IMPROVED SELECTIVITY, TARGET MODULATION, AND CARDIAC SAFETY IN PATIENTS WITH LYMPHOMA

• DOI: 10.1097/01.hs9.0000847940.03718.3d
• Publication Date: 2022-06-23T14:34:01Z
• Authors: M. Frigault; S. Sher; J. Ravikrishnan; R. Izumi; J. Ware; H. Wong; A. Johnson; B. Stelte-Ludwig; J. Byrd; D. Sampath; K. Rogers; J. Woyach; R. Lapalombella; A. Hamdy
• Keywords: 0303 health sciences; 03 medical and health sciences; Posters; Diseases of the blood and blood-forming organs; RC633-647.5